**Model Output Assessment — Case 1 / MCL**

Gemma 4 RAG performs well on this case and can be used as a **concordant positive example**.

The model ranks **Mucocutaneous Leishmaniasis (MCL)** first, which is clinically reasonable given the input. The case contains several strong MCL signals: a patient from Syria, a prior arm scar suggestive of previous cutaneous leishmaniasis, and severe mucosal involvement of the pharynx and larynx with swollen epiglottis, uvula, and papilloma-like lesions. This pattern is consistent with mucosal progression after earlier cutaneous disease.

The retrieved evidence is also well aligned with the model’s conclusion. The top retrieved chunk concerns **palatal and nasal mucosal disease in leishmaniasis**, followed by cutaneous and visceral leishmaniasis support. Unlike the PKDL case, the retrieval does not strongly pull the model toward an unrelated subtype. In this case, the RAG evidence supports the same disease family and subtype direction as the clinical input.

The model’s **high confidence** is understandable because the clinical presentation is more specific than the other examples. However, for thesis defense, this should still be framed as **high model confidence**, not clinical certainty. The model correctly states that definitive confirmation requires tissue sampling or laboratory/histopathological testing.

The main wording weakness is the phrase:

> “The visual evidence from the attached image confirms…”

This is too strong. A safer interpretation would be:

> “The image is visually consistent with papillomatous-appearing mucosal lesions, but image evidence alone is not diagnostic.”

**Conclusion:**
This is a strong case-level success example. Gemma 4 RAG correctly ranks MCL first, and the prediction is supported by both the clinical description and retrieved mucosal-leishmaniasis evidence. The case is useful for demonstrating that RAG can help when the retrieved evidence is well matched to the patient presentation. However, the output should still be presented as research decision support, not a validated clinical diagnosis.
